Published in Cancer Res on November 15, 2006
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A (2007) 5.50
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med (2012) 5.46
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest (2007) 4.76
MicroRNAs in cancer. Annu Rev Pathol (2009) 4.47
Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol (2007) 4.40
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci (2008) 4.28
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res (2008) 3.67
Epigenetics and environmental chemicals. Curr Opin Pediatr (2009) 2.83
Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood (2007) 2.83
Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem (2008) 2.81
Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation (2009) 2.70
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One (2011) 2.70
Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J (2008) 2.58
Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab (2007) 2.52
MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol (2008) 2.39
MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol Immunol (2007) 2.24
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol (2010) 2.20
An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect (2010) 2.16
MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res (2009) 2.13
Environmental chemical exposures and human epigenetics. Int J Epidemiol (2011) 1.97
RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ Health Perspect (2008) 1.95
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med (2011) 1.94
A simple array platform for microRNA analysis and its application in mouse tissues. RNA (2007) 1.91
Epigenetics in the placenta. Am J Reprod Immunol (2009) 1.77
Dicer is regulated by cellular stresses and interferons. Mol Immunol (2008) 1.69
Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget (2012) 1.65
MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders. Curr Genomics (2009) 1.60
Radiation modulation of microRNA in prostate cancer cell lines. Prostate (2008) 1.58
miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol (2010) 1.54
Epigenetics: A New Bridge between Nutrition and Health. Adv Nutr (2010) 1.51
Technical variables in high-throughput miRNA expression profiling: much work remains to be done. Biochim Biophys Acta (2008) 1.36
mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol (2009) 1.34
Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol (2010) 1.33
Toxicogenomic profiling of chemically exposed humans in risk assessment. Mutat Res (2010) 1.30
Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. Small (2008) 1.29
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. PLoS One (2011) 1.29
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease. Immune Netw (2011) 1.29
MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J Alzheimers Dis (2010) 1.26
miRNAs: effectors of environmental influences on gene expression and disease. Toxicol Sci (2008) 1.21
Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) (2010) 1.17
Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics (2010) 1.17
Arsenic exposure and the induction of human cancers. J Toxicol (2011) 1.16
Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations. Health Phys (2013) 1.14
Bioinformatic and genetic association analysis of microRNA target sites in one-carbon metabolism genes. PLoS One (2011) 1.14
ARS2 is a conserved eukaryotic gene essential for early mammalian development. Mol Cell Biol (2007) 1.10
Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J (2012) 1.10
Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol Sci (2011) 1.09
Folic acid remodels chromatin on Hes1 and Neurog2 promoters during caudal neural tube development. J Biol Chem (2010) 1.09
MicroRNAs in mental health: from biological underpinnings to potential therapies. Neuromolecular Med (2009) 1.09
Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res (2012) 1.06
Environmental chemicals and microRNAs. Mutat Res (2011) 1.05
MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol Carcinog (2011) 1.04
Cancer microRNAs: from subtype profiling to predictors of response to therapy. Trends Mol Med (2011) 1.03
Whole mouse blood microRNA as biomarkers for exposure to γ-rays and (56)Fe ion. Int J Radiat Biol (2011) 1.03
Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity. PLoS One (2012) 1.02
Epigenomics in environmental health. Front Genet (2011) 1.02
MicroRNA, nutrition, and cancer prevention. Adv Nutr (2011) 1.02
Deep sequencing reveals important roles of microRNAs in response to drought and salinity stress in cotton. J Exp Bot (2014) 1.00
The dynamic stress-induced "O-GlcNAc-ome" highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways. Amino Acids (2010) 0.98
Biomarkers of Nutrition for Development-Folate Review. J Nutr (2015) 0.98
MicroRNA-24 regulates the processing of latent TGFβ1 during cyclic mechanical stress in human trabecular meshwork cells through direct targeting of FURIN. J Cell Physiol (2011) 0.98
Identification of microRNAs associated with hyperthermia-induced cellular stress response. Cell Stress Chaperones (2010) 0.97
MicroRNA-mediated repression of nonsense mRNAs. Elife (2014) 0.96
Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions. PLoS One (2013) 0.96
Behavioral plasticity in honey bees is associated with differences in brain microRNA transcriptome. Genes Brain Behav (2012) 0.95
Small RNA expression profiling by high-throughput sequencing: implications of enzymatic manipulation. J Nucleic Acids (2012) 0.94
Epigenetics across the human lifespan. Front Cell Dev Biol (2014) 0.93
Influence of environmental exposure on human epigenetic regulation. J Exp Biol (2015) 0.93
Diet, microRNAs and prostate cancer. Pharm Res (2010) 0.93
Interplay between the oxidoreductase PDIA6 and microRNA-322 controls the response to disrupted endoplasmic reticulum calcium homeostasis. Sci Signal (2014) 0.91
Incorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead, and mercury: strategies and challenges. Front Genet (2014) 0.90
Influence of toxicologically relevant metals on human epigenetic regulation. Toxicol Res (2015) 0.89
Epigenetics and its implications for ecotoxicology. Ecotoxicology (2011) 0.89
Chimeric tRNAs as tools to induce proteome damage and identify components of stress responses. Nucleic Acids Res (2009) 0.88
Posttranslational modification of Argonautes and their role in small RNA-mediated gene regulation. Silence (2011) 0.88
Cancer stem cells: potential target for bioactive food components. J Nutr Biochem (2012) 0.86
Diet and aging. Oxid Med Cell Longev (2012) 0.86
Intra-relation reconstruction from inter-relation: miRNA to gene expression. BMC Syst Biol (2013) 0.86
MicroRNA and cancer chemoprevention. Cancer Prev Res (Phila) (2013) 0.86
MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutat Res (2012) 0.85
microRNA expression and biogenesis in cellular response to ionizing radiation. DNA Cell Biol (2014) 0.84
The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol (2014) 0.84
Micro(RNA)managing endoplasmic reticulum stress. IUBMB Life (2013) 0.83
Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk. Front Genet (2012) 0.83
miR-3928 activates ATR pathway by targeting Dicer. RNA Biol (2012) 0.83
Integration analysis of microRNA and mRNA expression profiles in human peripheral blood lymphocytes cultured in modeled microgravity. Biomed Res Int (2014) 0.83
Interactome of Radiation-Induced microRNA-Predicted Target Genes. Comp Funct Genomics (2012) 0.82
Molecular features in arsenic-induced lung tumors. Mol Cancer (2013) 0.82
Differential miRNA expression profiles in proliferating or differentiated keratinocytes in response to gamma irradiation. BMC Genomics (2013) 0.82
CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells. Oncotarget (2015) 0.82
MicroRNA-133α regulates neurotensin-associated colonic inflammation in colonic epithelial cells and experimental colitis. RNA Dis (2015) 0.81
MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort. Exp Mol Med (2015) 0.80
Early methyl donor deficiency may induce persistent brain defects by reducing Stat3 signaling targeted by miR-124. Cell Death Dis (2013) 0.80
Cell survival following radiation exposure requires miR-525-3p mediated suppression of ARRB1 and TXN1. PLoS One (2013) 0.80
Proton radiation-induced miRNA signatures in mouse blood: characterization and comparison with 56Fe-ion and gamma radiation. Int J Radiat Biol (2012) 0.80
Specific Roles of MicroRNAs in Their Interactions with Environmental Factors. J Nucleic Acids (2012) 0.80
MicroRNA profiling in human colon cancer cells during 5-fluorouracil-induced autophagy. PLoS One (2014) 0.79
Analysis of the transcriptome in molecular epidemiology studies. Environ Mol Mutagen (2013) 0.79
Hypoxia represses microRNA biogenesis proteins in breast cancer cells. BMC Cancer (2014) 0.79
Interaction of Serum microRNAs and Serum Folate With the Susceptibility to Pancreatic Cancer. Pancreas (2015) 0.79
DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics (2012) 9.31
Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet (2009) 7.07
Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2007) 4.01
Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics (2008) 3.89
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res (2007) 2.93
DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst (2010) 2.87
Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst (2007) 2.68
A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst (2009) 2.40
A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. Carcinogenesis (2009) 2.28
Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res (2002) 2.20
Recommendations for the design and analysis of epigenome-wide association studies. Nat Methods (2013) 2.19
MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res (2009) 2.13
Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res (2010) 2.10
Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis (2005) 2.08
Nightshift work and genome-wide DNA methylation. Chronobiol Int (2014) 2.01
Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis (2009) 1.94
DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol (2011) 1.92
Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene (2004) 1.82
Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev (2010) 1.81
Blood-based profiles of DNA methylation predict the underlying distribution of cell types: a validation analysis. Epigenetics (2013) 1.79
Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer (2007) 1.78
Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers. Cancer Epidemiol Biomarkers Prev (2012) 1.76
Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res (2012) 1.76
Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet (2010) 1.74
Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res (2009) 1.73
Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol (2009) 1.70
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol (2005) 1.67
The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev (2005) 1.64
Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics (2010) 1.63
A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet Epidemiol (2009) 1.61
LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer (2011) 1.56
High-risk HPV types and head and neck cancer. Int J Cancer (2014) 1.56
Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis (2005) 1.55
Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer (2006) 1.53
Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res (2006) 1.52
Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene (2002) 1.49
A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res (2002) 1.45
Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev (2005) 1.44
Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res (2010) 1.44
Bladder cancer SNP panel predicts susceptibility and survival. Hum Genet (2009) 1.43
Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res (2009) 1.43
Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res (2005) 1.40
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis (2007) 1.40
Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study. Epigenetics (2012) 1.35
A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst (2002) 1.33
Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. J Urol (2007) 1.33
Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.33
Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene (2002) 1.33
Enabling personal genomics with an explicit test of epistasis. Pac Symp Biocomput (2010) 1.33
Quantitative reconstruction of leukocyte subsets using DNA methylation. Genome Biol (2014) 1.32
DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro Oncol (2011) 1.29
Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 1.29
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis (2009) 1.29
Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. BMC Urol (2007) 1.28
Global methylation in exposure biology and translational medical science. Environ Health Perspect (2011) 1.28
Identification of methylated genes associated with aggressive bladder cancer. PLoS One (2010) 1.27
Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.25
DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered (2007) 1.25
Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res (2006) 1.23
Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev (2007) 1.22
Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Int J Cancer (2005) 1.20
ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol (2005) 1.19
The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res (2002) 1.19
Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol (2007) 1.19
Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev (2002) 1.17
DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology (2007) 1.15
Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res (2011) 1.15
A novel survival multifactor dimensionality reduction method for detecting gene-gene interactions with application to bladder cancer prognosis. Hum Genet (2010) 1.14
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev (2011) 1.14
Teen smoking, field cancerization, and a "critical period" hypothesis for lung cancer susceptibility. Environ Health Perspect (2002) 1.14
Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis (2008) 1.14
DNA Methylation in Whole Blood: Uses and Challenges. Curr Environ Health Rep (2015) 1.14
The influence of aging, environmental exposures and local sequence features on the variation of DNA methylation in blood. Epigenetics (2011) 1.13
Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis (2009) 1.13
Integrative DNA methylation and gene expression analyses identify DNA packaging and epigenetic regulatory genes associated with low motility sperm. PLoS One (2011) 1.13
Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles. Cancer Res (2009) 1.12
Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Carcinogenesis (2002) 1.09
Selenium and risk of bladder cancer: a population-based case-control study. Cancer Prev Res (Phila) (2009) 1.09
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma. Int J Cancer (2010) 1.09
Copy number variation has little impact on bead-array-based measures of DNA methylation. Bioinformatics (2009) 1.08
A robust multifactor dimensionality reduction method for detecting gene-gene interactions with application to the genetic analysis of bladder cancer susceptibility. Ann Hum Genet (2010) 1.07
Decreased NK cells in patients with head and neck cancer determined in archival DNA. Clin Cancer Res (2012) 1.06
A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck. Clin Cancer Res (2008) 1.06
Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted. PLoS One (2010) 1.05
Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett (2005) 1.05
Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2006) 1.04
Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer (2008) 1.03
Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis (2008) 1.03
TP53 mutation, allelism and survival in non-small cell lung cancer. Carcinogenesis (2005) 1.03
Lead burden and psychiatric symptoms and the modifying influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism: the VA Normative Aging Study. Am J Epidemiol (2007) 1.02
Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer (2009) 1.02
Dietary folate is associated with p16(INK4A) methylation in head and neck squamous cell carcinoma. Int J Cancer (2006) 1.02
Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders. Epigenetics (2011) 1.01
Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans. Hum Mol Genet (2010) 0.99
A population-based case-control study of marijuana use and head and neck squamous cell carcinoma. Cancer Prev Res (Phila) (2009) 0.97